Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel

    Pharmacogenomics, Vol. 23, Núm. 11, pp. 627-638